Christoph Male, MD, MSc

Head of the Pediatric Hemostasis & Thrombosis Unit
Department of Paediatrics, Medical University of Vienna, Vienna, Austria.

CHRISTOPH MALE, MD, MSc

Christoph Male is consultant and associate professor at the Department of Paediatrics, Medical University of Vienna, Austria, where he is director of the Paediatric Haemostasis & Thrombosis unit. He holds a degree in Health Research Methodology from McMaster University, Canada. His scientific interest is in paediatric haemostasis & thrombosis, clinical trials methodology, and drug evaluation in children. He has more than 20 years of experience in clinical research and is actively involved in several academic or industry-sponsored clinical trials in children.
Christoph Male is immediate past chair of the Pediatric SSC of the ISTH, vice chair of the PedNet Haemophilia Foundation, chair of the Scientific Board of the Austrian Haemophilia Society, and past board member of the German-Austrian-Swiss Society of Thrombosis and Haemostasis Research (GTH). He served as Austrian delegate in the Paediatric Committee at the European Medicines Agency from 2007-2016.

Presentation(s):

• SSC 04.02 - Update from Antithrombotic Trials Working Group

  Saturday, July 9, 2022
  2:40 PM – 2:50 PM

• SOA 03.3 - How Might We Better Design Pediatric (Anticoagulant) Trials in the Future?

  Sunday, July 10, 2022
  8:40 AM – 9:00 AM

• OC 15.2 - The SAXOPHONE Study; A Multi-Center, Multi-National Randomized Trial of Apixaban versus Standard of Care Anticoagulation for Thromboprophylaxis in Children with Congenital or Acquired Heart Disease

  Sunday, July 10, 2022
  11:00 AM – 11:15 AM

• OC 15.5 - Validating Direct Oral Anticoagulants (DOAC) for Use in Children by the Throm-PED DOAC Registry of the International Pediatric Thrombosis Network

  Sunday, July 10, 2022
  11:45 AM – 12:00 PM

• OC 27.1 - The type and frequency of bleeds in 870 children with severe hemophilia A and B on primary prophylaxis: Data from the PedNet study group

  Sunday, July 10, 2022
  2:45 PM – 3:00 PM

• PB0254 - Effects of apixaban versus vitamin K antagonists and low molecular weight heparin in pediatric cardiac patients: exploratory biomarker analysis from SAXOPHONE a multicentre randomized clinical trial

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0276 - Real World Data of Pediatric Thromboembolic Disease by the International Pediatric Thrombosis Network

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 63.3 - Safety and Efficacy of Recombinant Factor IX Fusion Protein (rIX-FP) in Previously Untreated Patients with Hemophilia B

  Tuesday, July 12, 2022
  3:15 PM – 3:30 PM

• OC 63.4 - Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)

  Tuesday, July 12, 2022
  3:30 PM – 3:45 PM

• SOA 25.4 - Hemostasis and Thrombosis in Children With Infectious/Inflammatory Disease

  Wednesday, July 13, 2022
  8:30 AM – 9:45 AM